| Anti-4E6 1 mg/ml, diluted 1:25, was added to wells that had been coated with the different mouse mAbs. The amount of rabbit lgG that hound was detected by incubation with "Sldabeled goat anti-rabbit IgG. ! Preimmune rabbit lg.
As a control, 'SSl-goat anti-mouse lgG was added to ensure that all wells were coated with approximately equal quantities of mouse lg.
Solid-Phase RIA. Microtiter plates were coated with antigen or antibody (1 ~g/well) essentially as described previously (4) . Samples were tested in triplicate and the binding of m~I-labeled Ig was determined.
Immunofluorescence. The antibodies were tested for tissue reactivity by indirect immunofluorescence (1, 3).
Results
The specificity of affinity-purified anti-4E6 is shown in Table I . Anti-4E6 reacted with 4E6, but not with other mouse mAbs belonging to the same isotype and subclass.
To see whether anti-4E6 reacted with the same epitope on 4E6 with which MOR-h 1 reacted, various concentrations of MOR-h 1 were mixed with a constant amount of anti-4E6 and added to 4E6-coated wells. As seen in Fig. 1 A, MORh 1, and not pooled human IgM, inhibited the binding of anti-4E6 to 4E6. The data suggest that anti-4E6 and MOR-h 1 interact with the same epitope on 4E6.
To determine if the antigen-binding specificity of anti-4E6 was similar to that of MOR-hl, the binding of these antibodies to wells coated with hGH, 35 kD protein, or gelatin was tested. Table II shows that both anti-4E6 and MOR-hl reacted with hGH and 35 kD protein, but not with gelatin.
To test whether MOR-h 1 and anti-4E6 were reacting with the same or different epitopes on the hGH molecule, various concentrations of MOR-hl were added, along with a constant amount of anti-4E6, to hGH-coated wells. Fig. 1B shows that MOR-hl competed with anti-4E6 for binding to hGH. This argues that MOR-hl and anti-4E6 are recognizing the same epitope or epitopes in close proximity to each other on hGH.
To see whether the binding of anti-4E6 to hGH could be inhibited by 4E6, various concentrations of 4E6 were mixed with a constant amount of anti-4E6 and added to hGH-coated wells. Fig. 1 C shows that the binding of anti-4E6 to hGH was inhibited by 4E6 and not by MOPC-21. Taken together, these experiments strongly suggest that both 4E6 and hGH are reacting with the paratope of anti-4E6. To determine what proportion of the Ig molecules in our anti-4E6 preparation were capable of binding to hGH, different concentrations of hGH were incubated with a constant amount of anti-4E6 and then added to 4E6-coated wells. Fig. 1 D shows that the binding of anti-4E6 to 4E6 was inhibited by hGH but not by gelatin. Moreover, when anti-4E6 was absorbed with hGH, >90% of its reactivity with the tissues was eliminated (not shown). Taken together, these studies BRIEF D E F I N I T I V E R E P O R T * Wells were coated with 0.5/~g/well of either hGH, 35kD protein, or gelatin and then incubated with the first antibody. * The binding of anti-4E6, normal rabbit serum and anti-hGH antibody was quantitated with J2SI-labeled antirabbit lgG, and the binding of MOR-hl was quantitated with E~I-labeled anti-human IgM. ! cpm + SD bound to wells. M Preimmune normal rabbit serum. FIGURE 2. Indirect Immunofluorescence. Reactivity of MOR-h I (A, C, a n d E) a n d anti-4E6 (B, D, a n d F) with stomach (A and B), thyroid (C and D), a n d a n t e r i o r pituitary (E and F).
Original magnification x 100. strongly argue that the binding specificity for both 4E6 and hGH reside in the same Ig molecules of the anti-4E6 preparation and that the majority of them are of the internal image type.
To see whether anti-4E6 also reacts with multiple organs, normal tissues were stained with MOR-hl and anti-4E6. As seen in Fig. 2 , both MOR-hl and anti-4E6 reacted with stomach (Fig. 2, A and B) , thyroid (C and D), and anterior pituitary (Fig. 2, E and F) . By double immunofluorescence (3), the same cells were stained by both antibodies (not shown). Thus, anti-4E6 is an IgG multiple organ-reactive antibody with a specificity similar to that of MOR-hl.
Discussion
Previously, we reported the production of human IgM monocional autoantibodies (Abl) in vitro that reacted with multiple organs (1, 2) . The present experiments show that animals immunized with a monoclonai anti-idiotypic antibody (Ab2) to an Abl can make IgG antibodies that have MOR activity. Thus, MOR antibodies are not an artifact of in vitro procedures, nor are they limited to the IgM class. Moreover, these experiments suggest that it is possible to raise autoantibodies without immunizing the host with autoantigens.
Studies from several laboratories have shown that Ab2 made to paratopes of Abl that react with certain ligands (e.g., insulin and Bis Q) can bind to corresponding receptors for these ligands and, in some cases, can trigger an experimental autoimmune disease (6, 7) . It is thought that the paratope of these Ab2s are complementary to the paratope of Abl. Several groups have also made antianti-idiotypic antibodies (Ab3). These latter antibodies have shown several different types of reactivity (5, 8) . Some are directed against framework determinants on Ab2 and do not show Abl like activity; others react with the paratope of Ab2 but are not internal images and fail to show Abl-like antigen binding activity; and still others react with the paratope of Ab2 and show Abl-like antigen-binding activity. Our Ab3 belongs to this latter Category. The 4E6 paratope (Ab2) appears to have a conformational resemblance to an epitope on hGH and the 35 kD protein and thus can elicit an antibody (Ab3) that reacts with these ligands.
Since some Ab2s have conformational similarities to the ligands with which Abl react, they have been used with success to elicit antibodies against viruses, trypanosomes, and histocompatibility antigens (9) . The present work and the recent report by Zanetti et al. (10) show that anti-idiotypic antibodies can also induce autoantibodies. This raises the possibility that stimulation of autoreactive B iymphocytes present in the normal B cell repertoire (11) by Ab2 may be one of the mechanisms for triggering autoimmunity. In fact, some anti-idiotypic antibodies are known to have public specificity (4, 8) , and several Ig families bearing specific idiotypes have been implicated in certain autoimmune diseases (12) . Along these lines, it is interesting to speculate whether stimulation of a family of B lymphocytes by broadly reactive anti-idiotypic antibodies could result in the production of a spectrum of autoantibodies with different organ specificities as in systemic lupus erythematosus or polyendocrine disease. If this turns out to be the case, then it is conceivable that clonal proliferation of a single antiidiotypic antibody could trigger an autoimmune cascade (2). Summary MOR-h 1 is a human multiple organ-reactive (MOR) monocional autoantibody (Abl) that reacts with human growth hormone (hGH) and a 35 kD protein found in the anterior pituitary, thyroid, stomach, and pancreas. 4E6 is a mouse mono-clonal anti-idiotypic antibody (Ab2) that reacts with the paratope of MOR-h and is ligand inhibitable. In the present study, we immunized a rabbit with 4E and purified an IgG fraction (anti-4E6) from the sera. Competitive inhibitio experiments showed that anti-4E6 (Ab3) binds to the same epitope on 4E6 an to the same antigens (i.e., hGH and 35 kD protein) as does MOR-hl. B immunofluorescence, anti-4E6, an IgG antibody, shows the same multiple orga reactivity with tissues as does MOR-hl, an IgM antibody. From these and othe studies, we conclude that the 4E6 paratope (Ab2) has a conformational reseat blance to an epitope on hGH and the 35 kD protein. This raises the possibilit that antibodies made in response to certain anti-idiotypic antibodies may be on of the mechanisms for triggering an autoimmune response. 4 March 1986. 
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